Barclays’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-59
Closed -$1.86K 5585
2026
Q1
$1.86K Buy
+59
New +$1.86K ﹤0.01% 4862
2025
Q4
Sell
-33,438
Closed -$844K 5614
2025
Q3
$844K Buy
+33,438
New +$815K ﹤0.01% 3469
2024
Q4
Sell
-303,000
Closed -$7.55M 5448
2024
Q3
$7.55M Buy
+303,000
New +$8.97M ﹤0.01% 1699
2023
Q3
Sell
-34
Closed -$1.33K 4688
2023
Q2
$1.33K Hold
34
﹤0.01% 4346
2023
Q1
$1.24K Hold
34
﹤0.01% 4915
2022
Q4
$1.05K Buy
+34
New +$1.05K ﹤0.01% 5116

Other funds holding RTO

Barclays's RTO Position: Q2 2026 in Review

Barclays sold out of Rentokil (RTO) in Q2 2026, closing a stake of 59 shares — an estimated $1.86K sold.

Barclays first reported a position in RTO in Q4 2022 and held it in 6 quarters. The position peaked at $7.55M in Q3 2024. 285 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Barclays reported no remaining Rentokil position as of Q2 2026 after selling out during the quarter.
  • Barclays sold 59 Rentokil shares in Q2 2026, an estimated $1.86K.
  • Barclays first reported a position in Rentokil in Q4 2022 and held it in 6 quarters.
  • Barclays's Rentokil position peaked at $7.55M in Q3 2024.
  • 285 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.